Inspec

Inspec Total Assets

The Total Assets of Inspec (6656.T) as of Nov 13, 2026 is 3.74 B JPY. In the previous year, Total Assets was 3.02 B JPY — a change of 23.66% (higher).

Total Assets

3.74 BJPY

YoY

23.66%

Last updated:

Total Assets of Inspec is 2026 3.74 B JPY. Total Assets of Inspec was 2025 3.02 B JPY. It decreases by 23.66% higher compared to the previous year.

The Inspec Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2019
3.03 B JPY
Jan 1, 2020
3.76 B JPY
Jan 1, 2021
2.70 B JPY
Jan 1, 2022
3.28 B JPY
Jan 1, 2023
4.01 B JPY
Jan 1, 2024
3.76 B JPY
Jan 1, 2025
3.02 B JPY
Jan 1, 2026
3.74 B JPY
The Inspec Total Assets history
YEARTotal AssetsYoY
3.74 BJPY+23.66%
3.02 BJPY-19.68%
3.76 BJPY-6.05%
4.01 BJPY+22.24%
3.28 BJPY+21.41%
2.70 BJPY-28.16%
3.76 BJPY+24.17%
3.03 BJPY+0.42%
3.01 BJPY+21.00%
2.49 BJPY+17.74%
2.12 BJPY+3.25%
2.05 BJPY+62.54%
1.26 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Total Assets of Inspec is 3.74 B JPY in 2026.

Total Assets of Inspec changed from 3.02 B JPY to 3.74 B JPY, representing a 23.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Inspec since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Inspec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Inspec

All Key Metrics — Inspec